Welcome to our dedicated page for Qualys SEC filings (Ticker: QLYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Qualys, Inc. filings document the regulatory disclosures of a Delaware software company providing cloud-based IT, security and compliance solutions. Its 8-K reports furnish quarterly and annual financial results, including GAAP and non-GAAP operating measures, guidance and conference-call materials.
Proxy materials cover annual meeting mechanics, Class II director elections, auditor ratification, advisory executive compensation votes and amendments to the 2012 Equity Incentive Plan. The filings also reflect public-company governance, common-stock voting matters and compensation-plan disclosures.
Bruce K. Posey, Chief Legal Officer of Qualys, Inc. (QLYS), reported two share dispositions executed on 09/22/2025 under a Rule 10b5-1 trading plan adopted on August 21, 2024. The Form 4 shows a sale of 270 shares at a weighted-average price of $135.9405, followed by a sale of 255 shares at a weighted-average price of $136.4424. The filing discloses ranges for the underlying prices: $135.28–$136.24 and $136.29–$136.63, and lists the reporter's beneficial ownership after the trades as 57,570 and 57,315 shares respectively. The Form is signed and dated 09/23/2025.
Bruce K. Posey, Chief Legal Officer of Qualys, Inc. (QLYS), reported two share dispositions executed on 09/22/2025 under a Rule 10b5-1 trading plan adopted on August 21, 2024. The Form 4 shows a sale of 270 shares at a weighted-average price of $135.9405, followed by a sale of 255 shares at a weighted-average price of $136.4424. The filing discloses ranges for the underlying prices: $135.28–$136.24 and $136.29–$136.63, and lists the reporter's beneficial ownership after the trades as 57,570 and 57,315 shares respectively. The Form is signed and dated 09/23/2025.
Insider transactions at Qualys, Inc. (QLYS) show the company's CEO and President, Sumedh S. Thakar, exercised options and sold shares on 09/15/2025 under a previously adopted trading plan. He exercised a fully vested option with a $25.56 exercise price to acquire 6,500 shares, and sold 8,500 shares in two transactions (5,801 shares at a weighted average of $132.2225 and 2,699 shares at a weighted average of $133.0718). After these transactions Thakar reported beneficial ownership of 205,951 shares. The sale transactions were effected pursuant to a Rule 10b5-1 plan adopted February 26, 2025, and the reported holdings include 31 shares acquired through the employee stock purchase plan.
Qualys, Inc. Chief Financial Officer Joo Mi Kim sold a total of 844 shares of Qualys common stock on 09/05/2025 under a pre-established Rule 10b5-1 trading plan adopted August 21, 2024. The three sale transactions show weighted average sale prices in ranges from $133.68 to $136.45 per share and resulted in reported beneficial ownership of 93,651 shares following the transactions. The filing also discloses an exempt purchase of 27 shares on August 15, 2025 through the company’s Employee Stock Purchase Plan. The Form 4 was signed by power of attorney on September 8, 2025.
Qualys, Inc. (QLYS) director Thomas Berquist reported sales of company common stock on 09/02/2025 executed under a Rule 10b5-1 trading plan adopted February 19, 2025. The Form 4 discloses three sale transactions: 150 shares at a weighted average price of $132.1767, 325 shares at $133.4115, and 37 shares at $133.93. Following these dispositions, the reported beneficial ownership totals shown on the form decreased from prior levels to 5,454; then 5,129; then 5,092 shares as reflected on each reported line.
The filing was signed on behalf of Mr. Berquist by power of attorney on 09/03/2025. The Form 4 notes that the seller will provide detailed per-price share counts to the Commission upon request. No derivative transactions, grants, or acquisitions are reported in this filing.
John A. Zangardi, a director of Qualys, Inc. (QLYS), sold 3,103 shares of the company's common stock on 08/27/2025 at a weighted average price of $134.9405 per share, with individual sale prices ranging from $134.50 to $135.46. After the sale, Mr. Zangardi beneficially owned 4,071 shares directly and 5 shares indirectly through his son. The Form 4 was filed as an individual filing and signed under power of attorney by Bruce Posey on 08/29/2025.
Qualys, Inc. (QLYS) Form 144 discloses a proposed Rule 144 sale of 5,295 common shares with an aggregate market value of $714,295, scheduled approximately for 08/27/2025 on Nasdaq. The shares were acquired as vested restricted stock grants on 06/12/2020 and were paid as equity compensation.
The filing identifies Charles Schwab as the broker and reports related recent sales by John A. Zangardi: 1,287 shares sold for $169,918 on 08/13/2025 and 3,860 shares sold for $520,403 on 08/22/2025. The total outstanding shares reported in the filing are 36,095,879, and the filer certifies no undisclosed material adverse information.
John A. Zangardi, a director of Qualys, Inc. (QLYS), reported the sale of 3,860 shares of the issuer's common stock on 08/22/2025. The filing shows the sale code "S" with a weighted average sale price of $134.8197, and an indicated price range of $134.575 to $135.12 per share. After the reported transaction the filing lists 7,174 shares beneficially owned directly and an indirect holding of 5 shares attributed to his son. The Form 4 was signed by Bruce Posey by power of attorney on 08/25/2025. This report is a Section 16 disclosure of insider selling and provides the weighted average price range for the shares sold.
Form 4 shows that Kristi Marie Rogers, a director of Qualys, Inc. (QLYS), sold 1,700 shares of the company's common stock on 08/22/2025 at a reported price of $134.7047 per share. After this sale she beneficially owned 8,596 shares, held directly. The filing was signed on 08/25/2025 by Bruce Posey as attorney-in-fact.
Qualys, Inc. (QLYS) Form 144 filed to report a proposed sale of 1,700 shares of common stock through Morgan Stanley Smith Barney LLC on 08/22/2025. The filing shows the shares were acquired on 06/07/2024 as restricted stock that vested under a registered plan and the acquisition was part of compensation. The aggregate market value of the proposed sale is listed as $229,313.00 and the company had 36,095,879 shares outstanding per the form. The filer indicates there were no other sales by the reporting person in the prior three months and provides the standard signature representation regarding material nonpublic information.
Bruce K. Posey, Chief Legal Officer of Qualys, Inc. (QLYS), reported sales of common stock on 08/20/2025 executed under a Rule 10b5-1 trading plan adopted on 08/21/2024. The Form 4 discloses three sale entries: 308 shares at a weighted average price of $131.8922, 192 shares at $132.7383, and 25 shares at $133.618, leaving the reporting person with 57,840 shares beneficially owned after the transactions.
The filing indicates the sales were planned pursuant to the pre-established 10b5-1 plan and provides price ranges for the component trades. The reporting person signed the Form 4 on 08/21/2025. All information above is taken directly from the filed Form 4.